Primary |
Asthma |
21.8% |
Chronic Obstructive Pulmonary Disease |
21.0% |
Drug Use For Unknown Indication |
10.9% |
Product Used For Unknown Indication |
5.9% |
Constipation |
5.0% |
Gastritis Prophylaxis |
4.2% |
Hypertension |
4.2% |
Cancer Pain |
3.4% |
Emphysema |
3.4% |
Pneumonia |
2.5% |
Prophylaxis |
2.5% |
Pulmonary Fibrosis |
2.5% |
Sedation |
2.5% |
Thrombosis Prophylaxis |
2.5% |
Candidiasis |
1.7% |
Obsessive-compulsive Disorder |
1.7% |
Thymoma Malignant |
1.7% |
Accidental Exposure |
0.8% |
Angina Pectoris |
0.8% |
Antifungal Prophylaxis |
0.8% |
|
Pharmaceutical Product Complaint |
16.7% |
Respiratory Arrest |
8.3% |
Angina Pectoris |
6.3% |
Dyspnoea |
6.3% |
Tachycardia |
6.3% |
Tremor |
6.3% |
Cyanosis |
4.2% |
Deafness Unilateral |
4.2% |
Hallucination, Auditory |
4.2% |
Hyperthyroidism |
4.2% |
Oropharyngeal Discomfort |
4.2% |
Overdose |
4.2% |
Pharyngeal Haemorrhage |
4.2% |
Toxic Epidermal Necrolysis |
4.2% |
Ventricular Fibrillation |
4.2% |
Vision Blurred |
4.2% |
Asthenia |
2.1% |
Blood Pressure Decreased |
2.1% |
Cardiac Discomfort |
2.1% |
Chest Discomfort |
2.1% |
|
Secondary |
Asthma |
44.5% |
Chronic Obstructive Pulmonary Disease |
9.5% |
Bronchitis |
6.2% |
Pulmonary Fibrosis |
4.3% |
Pneumonia |
3.8% |
Cardiac Failure |
3.3% |
Prophylaxis |
3.3% |
Thrombosis Prophylaxis |
3.3% |
Candidiasis |
2.8% |
Nausea |
2.8% |
Pain |
2.8% |
Stomatitis |
2.8% |
Gastritis |
1.9% |
Dyspepsia |
1.4% |
Osteoporosis Prophylaxis |
1.4% |
Sedation |
1.4% |
Sleep Disorder |
1.4% |
Bronchoscopy |
0.9% |
Cough |
0.9% |
Depression |
0.9% |
|
Toxic Epidermal Necrolysis |
11.5% |
Drug Exposure During Pregnancy |
7.7% |
Loss Of Consciousness |
7.7% |
Stevens-johnson Syndrome |
7.7% |
Swelling Face |
7.7% |
Ventricular Fibrillation |
7.7% |
Angina Pectoris |
3.8% |
Chest Pain |
3.8% |
Cholelithiasis |
3.8% |
Gastric Ulcer |
3.8% |
Neoplasm Malignant |
3.8% |
Rash |
3.8% |
Sinusitis |
3.8% |
Tachycardia |
3.8% |
Tooth Disorder |
3.8% |
Upper Respiratory Tract Inflammation |
3.8% |
Vomiting |
3.8% |
Weight Decreased |
3.8% |
Wheezing |
3.8% |
|
Concomitant |
Product Used For Unknown Indication |
26.5% |
Drug Use For Unknown Indication |
13.6% |
Asthma |
11.0% |
Chronic Obstructive Pulmonary Disease |
8.8% |
Prophylaxis Against Renal Transplant Rejection |
8.2% |
Hypertension |
5.4% |
Gastritis |
3.7% |
Prophylaxis |
3.3% |
Prophylaxis Against Transplant Rejection |
3.0% |
Tumour Pain |
2.5% |
Pneumonia |
2.3% |
Insomnia |
1.7% |
Bronchitis |
1.5% |
Non-small Cell Lung Cancer |
1.5% |
Thrombosis Prophylaxis |
1.3% |
Constipation |
1.3% |
Rheumatoid Arthritis |
1.2% |
Helicobacter Infection |
1.0% |
Renal Transplant |
1.0% |
Emphysema |
1.0% |
|
Asthma |
14.0% |
Wrong Technique In Drug Usage Process |
10.8% |
Weight Increased |
8.6% |
Chronic Obstructive Pulmonary Disease |
7.5% |
Pneumonia |
7.5% |
Cerebral Infarction |
4.3% |
Hepatitis Acute |
4.3% |
Vertigo |
4.3% |
Death |
3.2% |
Epididymitis |
3.2% |
Hypotension |
3.2% |
Oedema Peripheral |
3.2% |
Pain In Extremity |
3.2% |
Restlessness |
3.2% |
Toxic Epidermal Necrolysis |
3.2% |
Urinary Retention |
3.2% |
Uterine Cancer |
3.2% |
Ventricular Extrasystoles |
3.2% |
Vomiting |
3.2% |
Wound Dehiscence |
3.2% |
|